These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 9242550

  • 1. Characterization of the retinoid binding properties of the major fusion products present in acute promyelocytic leukemia cells.
    Benedetti L, Levin AA, Scicchitano BM, Grignani F, Allenby G, Diverio D, Lo Coco F, Avvisati G, Ruthardt M, Adamo S, Pelicci PG, Nervi C.
    Blood; 1997 Aug 01; 90(3):1175-85. PubMed ID: 9242550
    [Abstract] [Full Text] [Related]

  • 2. A retinoid-resistant acute promyelocytic leukemia subclone expresses a dominant negative PML-RAR alpha mutation.
    Shao W, Benedetti L, Lamph WW, Nervi C, Miller WH.
    Blood; 1997 Jun 15; 89(12):4282-9. PubMed ID: 9192750
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Interferon augments PML and PML/RAR alpha expression in normal myeloid and acute promyelocytic cells and cooperates with all-trans retinoic acid to induce maturation of a retinoid-resistant promyelocytic cell line.
    Nason-Burchenal K, Gandini D, Botto M, Allopenna J, Seale JR, Cross NC, Goldman JM, Dmitrovsky E, Pandolfi PP.
    Blood; 1996 Nov 15; 88(10):3926-36. PubMed ID: 8916959
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARalpha-mediated increase of type II transglutaminase.
    Benedetti L, Grignani F, Scicchitano BM, Jetten AM, Diverio D, Lo Coco F, Avvisati G, Gambacorti-Passerini C, Adamo S, Levin AA, Pelicci PG, Nervi C.
    Blood; 1996 Mar 01; 87(5):1939-50. PubMed ID: 8634442
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Opposite effects of the acute promyelocytic leukemia PML-retinoic acid receptor alpha (RAR alpha) and PLZF-RAR alpha fusion proteins on retinoic acid signalling.
    Ruthardt M, Testa U, Nervi C, Ferrucci PF, Grignani F, Puccetti E, Grignani F, Peschle C, Pelicci PG.
    Mol Cell Biol; 1997 Aug 01; 17(8):4859-69. PubMed ID: 9234742
    [Abstract] [Full Text] [Related]

  • 9. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia.
    Guidez F, Ivins S, Zhu J, Söderström M, Waxman S, Zelent A.
    Blood; 1998 Apr 15; 91(8):2634-42. PubMed ID: 9531570
    [Abstract] [Full Text] [Related]

  • 10. The molecular genetics of acute promyelocytic leukemia.
    Grignani F, Fagioli M, Ferrucci PF, Alcalay M, Pelicci PG.
    Blood Rev; 1993 Jun 15; 7(2):87-93. PubMed ID: 8396481
    [Abstract] [Full Text] [Related]

  • 11. Genomic variability and alternative splicing generate multiple PML/RAR alpha transcripts that encode aberrant PML proteins and PML/RAR alpha isoforms in acute promyelocytic leukaemia.
    Pandolfi PP, Alcalay M, Fagioli M, Zangrilli D, Mencarelli A, Diverio D, Biondi A, Lo Coco F, Rambaldi A, Grignani F.
    EMBO J; 1992 Apr 15; 11(4):1397-407. PubMed ID: 1314166
    [Abstract] [Full Text] [Related]

  • 12. Acute promyelocytic leukemia: from clinic to molecular biology.
    Chen SJ, Wang ZY, Chen Z.
    Stem Cells; 1995 Jan 15; 13(1):22-31. PubMed ID: 7719245
    [Abstract] [Full Text] [Related]

  • 13. PML protein expression in hematopoietic and acute promyelocytic leukemia cells.
    Daniel MT, Koken M, Romagné O, Barbey S, Bazarbachi A, Stadler M, Guillemin MC, Degos L, Chomienne C, de Thé H.
    Blood; 1993 Sep 15; 82(6):1858-67. PubMed ID: 8400236
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Acute promyelocytic leukaemia and the t(15;17) translocation.
    Gillard EF, Solomon E.
    Semin Cancer Biol; 1993 Dec 15; 4(6):359-67. PubMed ID: 8142621
    [Abstract] [Full Text] [Related]

  • 17. Molecular analysis of the PML/RAR alpha chimeric gene in pediatric acute promyelocytic leukemia.
    Kane JR, Head DR, Balazs L, Hulshof MG, Motroni TA, Raimondi SC, Carroll AJ, Behm FG, Krance RA, Shurtleff SA, Downing JR.
    Leukemia; 1996 Aug 15; 10(8):1296-302. PubMed ID: 8709634
    [Abstract] [Full Text] [Related]

  • 18. Formation of PML/RAR alpha high molecular weight nuclear complexes through the PML coiled-coil region is essential for the PML/RAR alpha-mediated retinoic acid response.
    Grignani F, Gelmetti V, Fanelli M, Rogaia D, De Matteis S, Ferrara FF, Bonci D, Grignani F, Nervi C, Pelicci PG.
    Oncogene; 1999 Nov 04; 18(46):6313-21. PubMed ID: 10597230
    [Abstract] [Full Text] [Related]

  • 19. The PML-RAR alpha gene product of the t(15;17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells.
    Rousselot P, Hardas B, Patel A, Guidez F, Gäken J, Castaigne S, Dejean A, de Thé H, Degos L, Farzaneh F.
    Oncogene; 1994 Feb 04; 9(2):545-51. PubMed ID: 8290265
    [Abstract] [Full Text] [Related]

  • 20. Characterization of the PML-RAR alpha chimeric product of the acute promyelocytic leukemia-specific t(15;17) translocation.
    Nervi C, Poindexter EC, Grignani F, Pandolfi PP, Lo Coco F, Avvisati G, Pelicci PG, Jetten AM.
    Cancer Res; 1992 Jul 01; 52(13):3687-92. PubMed ID: 1319828
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.